MedTrace Logo

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00287521 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2012-03-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

Conditions

Interventions

DRUG

AL-37807 Ophthalmic Suspension, 1.0%

One drop in the study eye(s) once daily for 28 days

DRUG

Latanoprost, 0.005% (Xalatan)

One drop in the study eye(s) once daily for 28 days

OTHER

AL-37807 Vehicle

One drop in the study eye(s) once daily for 28 days

DRUG

Timolol Maleate Ophthalmic Gel Forming Solution, 0.5%

One drop in the study eye(s) once daily for 28 days

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2006-02-28
Completion
2006-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00287521 on ClinicalTrials.gov